Illicit Drug Production in China: A Retrospective Report
International Journal of Medical Toxicology and Forensic Medicine · 24.02.2026
DOI: 10.22037/ijmtfm.v16.50799 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Toxicology and Forensic Medicine, erschienen am 24.02.2026. Verfasst von Zhuoli Tao und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The vast Chinese synthetic drug market has given rise to numerous illicit drug production groups; empirical research on these groups remains limited.
Methods
In this study, the author collected data on 96 cases of illicit drug production from 2010 to 2020 through a website established by the Supreme Court of China.
Results
The findings revealed that the majority of these groups were located in Sichuan Province and Guangdong Province, both of which suffer from serious drug epidemics. Methamphetamine and ketamine were identified as the primary substances manufactured by these groups. Ephedrine and phenyl-2-propanone are commonly used as precursors in methamphetamine production, while hydroxyimide chloride is frequently utilized in the synthesis of ketamine.
Conclusion
To effectively combat such criminal activities, governments should enhance inter-regional cooperation to jointly address crimes related to drug production.
Schlagwörter
Zitieren
APA
Tao, Z., & Tao, S. (2026). Illicit Drug Production in China: A Retrospective Report. International Journal of Medical Toxicology and Forensic Medicine. https://doi.org/10.22037/ijmtfm.v16.50799
Vancouver
Tao Z, Tao S. Illicit Drug Production in China: A Retrospective Report. International Journal of Medical Toxicology and Forensic Medicine. 2026. doi:10.22037/ijmtfm.v16.50799
BibTeX
@article{Tao2026,
author = {Tao, Zhuoli and Tao, Sha},
title = {Illicit Drug Production in China: A Retrospective Report},
journal = {International Journal of Medical Toxicology and Forensic Medicine},
year = {2026},
doi = {10.22037/ijmtfm.v16.50799}
}
EUVIMED